PT-2399 | Interleukin Related interleukin-related.com

Product Name :
PT-2399

Search keywords :
PT2399

drugId :
null

Target Vo:
Ubiquitin-protein ligases

Target Vo Short Name :
Ubiquitin-protein ligases

Moa_Name:
Ubiquitin-protein ligases modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Peloton Therapeutics Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Neoplasms

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Adiponectin receptor protein 1 Rabbit mAb Biological Activity
Phospho-NF-κB p65(S529)Rabbit mAb manufacturer
LIN28A Antibody: LIN28A Antibody is a non-conjugated and Mouse origined monoclonal antibody about 23 kDa, targeting to LIN28A. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts